Brief Report - (2025) Volume 16, Issue 5
Received: 01-Oct-2025, Manuscript No. jbsbe-26-183316;
Editor assigned: 03-Oct-2025, Pre QC No. P-183316;
Reviewed: 17-Oct-2025, QC No. Q-183316;
Revised: 22-Oct-2025, Manuscript No. R-183316;
Published:
29-Oct-2025
, DOI: 10.37421/2165-6210.2025.16.522
Citation: Mansour, Khaled. ”Advancements in Nucleic Acid Biosensors for Diagnostics.” J Biosens Bioelectron 16 (2025):522.
Copyright: © 2025 Mansour K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The field of biosensing has witnessed significant advancements, particularly in the development of highly specific and sensitive detection platforms. Aptasensors and nucleic acid-based biosensors represent a cutting-edge area within this domain, leveraging the unique binding properties of nucleic acid molecules to target specific analytes [1].
These biosensors offer distinct advantages, including high specificity and affinity, making them invaluable for a wide range of applications from disease diagnostics to environmental monitoring [1].
Central to the efficacy of many nucleic acid-based biosensors is the catalytic activity of DNAzymes. These engineered DNA molecules possess enzymatic functions, enabling them to catalyze specific reactions that can be harnessed for signal amplification. The development of DNAzyme-based biosensors has focused on optimizing their configurations for the highly sensitive and selective detection of various analytes, including ions, small molecules, and biomacromolecules, which is crucial for point-of-care diagnostics [2].
A notable advancement in aptasensor design involves the synergistic integration of nanomaterials to enhance detection capabilities. For instance, a novel aptasensor utilizing a hybrid of graphene oxide and gold nanoparticles has been developed for the sensitive electrochemical detection of microRNA. The combined properties of these nanomaterials improve aptamer loading and signal transduction, leading to a significantly reduced limit of detection for disease biomarkers [3].
Beyond electrochemical detection, fluorescent aptasensors have also emerged as powerful tools for analyte detection. A study demonstrated the fabrication of a fluorescent aptasensor employing quantum dots and DNA aptamers for the sensitive and selective detection of lead ions. This approach capitalizes on the unique photophysical properties of quantum dots and the specific binding affinity of aptamers, proving critical for ensuring public health through environmental monitoring [4].
The pursuit of enhanced sensitivity and the enablement of point-of-care testing have driven the exploration of isothermal amplification techniques in nucleic acid-based biosensors. Various isothermal methods, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), are being integrated with aptamers or DNA probes. This integration facilitates rapid and efficient detection of pathogens and genetic markers without the need for thermal cycling [5].
For the detection of complex biological targets like cancer cells, sophisticated aptasensor designs are being developed. One such approach involves an electrochemical aptasensor that combines magnetic nanoparticles with DNA aptamers. This system effectively captures target cells and employs electrochemical signaling for sensitive and specific cell detection, presenting a promising tool for early cancer diagnosis [6].
A powerful emerging technology for highly sensitive and specific nucleic acid detection in biosensing applications is CRISPR-Cas12a. This system acts as a trans-cleavage enzyme upon recognizing its target, generating a detectable signal. Its application spans various fields, including pathogen detection and genetic analysis, owing to its precision and efficiency [7].
Impedimetric aptasensors offer another avenue for sensitive analyte detection. A novel impedimetric aptasensor designed for thrombin detection utilizes a gold electrode modified with methylene blue-labeled DNA aptamers. The binding of thrombin induces a distinct electrical signal, showcasing high sensitivity and specificity for this important biomarker [8].
The increasing demand for portable and accessible detection platforms has led to the development of smartphone-based biosensors. A smartphone-based fluorescent aptasensor has been engineered for the detection of organophosphorus pesticides. This system integrates aptamer recognition, fluorescent probes, and smartphone-based signal readout, offering a low-cost, portable, and rapid detection solution for agricultural and environmental safety [9].
Finally, the integration of metal-organic frameworks (MOFs) with aptasensors and nucleic acid biosensors is an area of active research. MOFs, with their exceptional properties like high surface area and tunable porosity, can significantly enhance biosensor performance. They improve analyte capture, signal amplification, and stability, leading to more sensitive and efficient detection systems across various applications [10].
The burgeoning field of aptasensors and nucleic acid-based biosensors is characterized by their remarkable specificity and affinity for target molecules, making them indispensable tools for disease diagnostics and environmental monitoring. These sophisticated systems integrate nucleic acid structures with advanced signal transduction mechanisms to achieve enhanced detection sensitivity [1].
The catalytic prowess of DNAzymes has been instrumental in the advancement of biosensor technology. DNAzyme-based biosensors utilize these engineered DNA molecules for signal amplification, enabling the highly sensitive and selective detection of a diverse array of analytes. This includes crucial applications in point-of-care diagnostics, where rapid and accurate identification of ions, small molecules, and biomacromolecules is paramount [2].
A significant stride in aptasensor design involves the strategic utilization of hybrid nanomaterials. The combination of graphene oxide and gold nanoparticles, for instance, has yielded an electrochemical aptasensor demonstrating exceptional sensitivity for microRNA detection. This synergistic approach enhances aptamer loading capacity and bolsters signal transduction efficiency, leading to a substantial reduction in the limit of detection for vital disease biomarkers [3].
Fluorescent aptasensors represent another promising class of detection platforms, as exemplified by their application in the detection of toxic heavy metals. A quantum dot-based fluorescent aptasensor, coupled with DNA aptamers, exhibits high sensitivity and selectivity for lead ions. This is crucial for safeguarding public health by enabling effective monitoring of environmental water samples [4].
The drive towards point-of-care testing and improved sensitivity has propelled the adoption of isothermal amplification techniques within nucleic acid-based biosensors. Methods such as LAMP and RPA are increasingly integrated with aptamers or DNA probes. This integration allows for rapid, efficient, and instrument-free detection of pathogens and genetic markers, expanding the accessibility of diagnostic tools [5].
Sophisticated designs are continually being developed for aptasensors targeting complex analytes like cancer cells. An electrochemical aptasensor employing magnetic nanoparticles and DNA aptamers has been engineered for sensitive and specific cancer cell capture and detection. This innovation holds significant promise for the advancement of early cancer diagnosis [6].
The revolutionary CRISPR-Cas12a system has opened new frontiers in highly sensitive and specific nucleic acid detection for biosensing. Its unique trans-cleavage activity upon target recognition allows for robust signal generation, finding diverse applications in pathogen identification and genetic analyses due to its inherent precision [7].
Impedimetric aptasensors offer a label-free approach to analyte detection, exemplified by an aptasensor designed for thrombin detection. This system, utilizing a gold electrode modified with specific aptamers, generates a measurable electrical signal change upon thrombin binding, demonstrating high sensitivity and specificity for this critical biomarker [8].
The development of portable and user-friendly detection systems is a key trend, as seen in the creation of smartphone-based fluorescent aptasensors. These devices can detect environmental contaminants such as organophosphorus pesticides by combining aptamer recognition with fluorescent probes and smartphone readout, offering a low-cost and accessible solution for safety monitoring [9].
The integration of advanced materials like metal-organic frameworks (MOFs) into aptasensors and nucleic acid biosensors is significantly enhancing their performance. MOFs contribute unique properties such as large surface areas and tailored porosity, which improve analyte binding, signal amplification, and overall sensor stability, leading to more robust and efficient biosensing systems [10].
This collection of research highlights advancements in biosensor technology, focusing on aptasensors and nucleic acid-based biosensors. These sensors offer high specificity and affinity for target molecules, finding applications in disease diagnostics and environmental monitoring. Key innovations include the use of DNAzymes for signal amplification, hybrid nanomaterials like graphene oxide and gold nanoparticles to enhance sensitivity, and quantum dots for fluorescent detection. Isothermal amplification techniques are being integrated for point-of-care testing. Novel designs involve magnetic nanoparticles for cell detection, CRISPR-Cas12a for precise nucleic acid identification, and impedimetric sensing for biomarkers. The development of smartphone-based sensors and the incorporation of metal-organic frameworks (MOFs) further expand the capabilities and accessibility of these biosensing platforms, promising more sensitive, rapid, and portable detection solutions.
None
None
Biosensors & Bioelectronics received 6207 citations as per Google Scholar report
